Gyre Therapeutics, Inc. GYRE US Equity
$6.59
-0.09 (-1.35%)
USD · as of 2026-08-28 · marketstack
Gyre Therapeutics, Inc. (Nasdaq: GYRE), an SEC filer in Pharmaceutical Preparations, closed at $6.59, -1.3%, on 2026-08-28, with a market cap of $745M as of 2026-08-27, a trailing P/E of 334.0, a return on equity of 11.7%, a net margin of 8.5% and 3-year sales growth of 4.5%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 1.7M |
| % of shares out | 1.6% |
| Days to cover | 31.1 |
| Δ vs 2026-07-31 | -4.3% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.